These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 8740246)
1. Yawning behavior for preclinical drug evaluation. Furukawa T Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):141-55. PubMed ID: 8740246 [No Abstract] [Full Text] [Related]
2. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors. Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712 [TBL] [Abstract][Full Text] [Related]
3. The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors. Kuzhikandathil EV; Bartoszyk GD Neuropharmacology; 2006 Sep; 51(4):873-84. PubMed ID: 16844149 [TBL] [Abstract][Full Text] [Related]
4. Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors. Seeman P Synapse; 2007 Dec; 61(12):1013-8. PubMed ID: 17853435 [TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Brocco M; Dekeyne A; Papp M; Millan MJ Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388 [TBL] [Abstract][Full Text] [Related]
12. Medications for Parkinson's disease. Whitney CM Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719 [No Abstract] [Full Text] [Related]
13. The role of catecholamines in the prolactin release induced by salsolinol. Székács D; Bodnár I; Vizi ES; Nagy GM; Fekete MI Neurochem Int; 2007 Oct; 51(5):319-22. PubMed ID: 17764787 [TBL] [Abstract][Full Text] [Related]
14. Markers of D(2) and D(3) receptor activity in vivo: PET scan and prolactin. Thomasson-Perret N; Pénélaud PF; Théron D; Gouttefangeas S; Mocaër E Therapie; 2008; 63(3):237-42. PubMed ID: 18718212 [TBL] [Abstract][Full Text] [Related]
15. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337 [TBL] [Abstract][Full Text] [Related]
16. Sex steroids are involved in the regulation of gonadotropin-releasing hormone and dopamine D2 receptors in female tilapia pituitary. Levavi-Sivan B; Biran J; Fireman E Biol Reprod; 2006 Oct; 75(4):642-50. PubMed ID: 16807382 [TBL] [Abstract][Full Text] [Related]
17. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole. Brown RW; Perna MK; Schaefer TL; Williams MT Synapse; 2006 Apr; 59(5):253-9. PubMed ID: 16408261 [TBL] [Abstract][Full Text] [Related]
18. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia. Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577 [TBL] [Abstract][Full Text] [Related]
19. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors. Seeman P; Ko F; Willeit M; McCormick P; Ginovart N Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951 [TBL] [Abstract][Full Text] [Related]
20. [Toxic and adverse neurological effects of anti-parkinsonian drugs]. Sunohara N Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715 [No Abstract] [Full Text] [Related] [Next] [New Search]